HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: A randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study.

Abstract
To evaluate the adequate therapeutic dosage of clomipramine 15 mg/day and clomipramine 30 mg/day in male patients with premature ejaculation (PE), this study enrolled men aged 20-65 years who met diagnostic criteria for PE including Intravaginal Ejaculation Latency Time (IELT) less than 2 min for at least 75% of their sexual intercourses. Subjects received placebo, clomipramine 15 mg, or clomipramine 30 mg prn (2~6 h before intercourse) for 4 weeks. Efficacy was assessed using fold change, percentile change, and mean change of IELT, as well as Drug Coitus Interval Time (DCIT). A total of 101 patients were randomized into the placebo group, clomipramine 15 mg group, and clomipramine 30 mg group. Analyses of fold changes of IELT in each group revealed that the IELT of both the clomipramine 15 mg group and clomipramine 30 mg group was significantly increased 4 weeks after administration than the placebo group. Adverse events were reported by 11.76, 32.35, and 57.57% of patients in the placebo group, clomipramine 15 mg group, and clomipramine 30 mg group, respectively. Most common adverse events in the clomipramine treatment groups were gastrointestinal disorders and psychiatric disorders of mild to moderate severity. On-demand regimen of clomipramine 15 mg resulted in a significant improvement in IELT and was superior to a regimen of clomipramine 30 mg in terms of risk-to-benefit ratio.
AuthorsSae Woong Kim, Jin Bong Choi, Su Jin Kim, Kyung Soo Kim, Churl Min Kim, Dong Hyeon Lee, Whan Seok Choi
JournalInternational journal of impotence research (Int J Impot Res) Vol. 30 Issue 2 Pg. 65-70 (Apr 2018) ISSN: 1476-5489 [Electronic] England
PMID29203842 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Serotonin Uptake Inhibitors
  • Clomipramine
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Clomipramine (administration & dosage, adverse effects, therapeutic use)
  • Double-Blind Method
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Premature Ejaculation (drug therapy)
  • Selective Serotonin Reuptake Inhibitors (administration & dosage, adverse effects, therapeutic use)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: